• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中药对肠道微生物群及微生物-肠-肝轴的调节作用

Modulatory effects of traditional Chinese medicines on gut microbiota and the microbiota-gut-x axis.

作者信息

Luo Tingting, Che Qingya, Guo Ziyi, Song Tingxia, Zhao Juanjuan, Xu Delin

机构信息

Department of Medical Instrumental Analysis, Zunyi Medical University, Zunyi, China.

Department of Cell Biology, Zunyi Medical University, Zunyi, China.

出版信息

Front Pharmacol. 2024 Oct 9;15:1442854. doi: 10.3389/fphar.2024.1442854. eCollection 2024.

DOI:10.3389/fphar.2024.1442854
PMID:39444598
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11497133/
Abstract

The gut microbiota offers numerous benefits to the human body, including the promotion of nutrient absorption, participation in metabolic processes, and enhancement of immune function. Recent studies have introduced the concept of the gut-organ axis, which encompasses interactions such as the gut-brain axis, gut-liver axis, and gut-lung axis. This concept underscores the complex interplay between gut microbiota and various organs and tissues, including the brain, heart, lungs, liver, kidneys, muscles, and bones. Growing evidence indicates that gut microbiota can influence the onset and progression of multi-organ system diseases through their effects on the gut-organ axis. Traditional Chinese medicine has demonstrated significant efficacy in regulating the gastrointestinal system, leveraging its unique advantages. Considerable advancements have been made in understanding the role of gut microbiota and the gut-organ axis within the mechanisms of action of traditional Chinese medicine. This review aims to elucidate the roles of gut microbiota and the gut-organ axis in human health, explore the potential connections between traditional Chinese medicine and gut microbiota, and examine the therapeutic effects of traditional Chinese medicine on the microbiota-gut-organ axis. Furthermore, the review addresses the limitations and challenges present in current research while proposing potential directions for future investigations in this area.

摘要

肠道微生物群对人体有诸多益处,包括促进营养吸收、参与代谢过程以及增强免疫功能。最近的研究引入了肠-器官轴的概念,其中包括肠-脑轴、肠-肝轴和肠-肺轴等相互作用。这一概念强调了肠道微生物群与包括大脑、心脏、肺、肝脏、肾脏、肌肉和骨骼在内的各种器官和组织之间的复杂相互作用。越来越多的证据表明,肠道微生物群可通过其对肠-器官轴的影响来影响多器官系统疾病的发生和发展。传统中医在调节胃肠系统方面已显示出显著疗效,发挥了其独特优势。在理解肠道微生物群和肠-器官轴在传统中医作用机制中的作用方面已取得了相当大的进展。本综述旨在阐明肠道微生物群和肠-器官轴在人类健康中的作用,探索传统中医与肠道微生物群之间的潜在联系,并研究传统中医对微生物群-肠-器官轴的治疗效果。此外,本综述还讨论了当前研究中存在的局限性和挑战,同时提出了该领域未来研究的潜在方向。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d62/11497133/507a7ecd4b5f/fphar-15-1442854-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d62/11497133/184123393296/fphar-15-1442854-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d62/11497133/b8a1ef312acc/fphar-15-1442854-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d62/11497133/e76bd3c474de/fphar-15-1442854-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d62/11497133/5a72b2d304e8/fphar-15-1442854-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d62/11497133/507a7ecd4b5f/fphar-15-1442854-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d62/11497133/184123393296/fphar-15-1442854-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d62/11497133/b8a1ef312acc/fphar-15-1442854-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d62/11497133/e76bd3c474de/fphar-15-1442854-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d62/11497133/5a72b2d304e8/fphar-15-1442854-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d62/11497133/507a7ecd4b5f/fphar-15-1442854-g005.jpg

相似文献

1
Modulatory effects of traditional Chinese medicines on gut microbiota and the microbiota-gut-x axis.中药对肠道微生物群及微生物-肠-肝轴的调节作用
Front Pharmacol. 2024 Oct 9;15:1442854. doi: 10.3389/fphar.2024.1442854. eCollection 2024.
2
Progress on traditional Chinese medicine in treatment of ischemic stroke via the gut-brain axis.基于肠-脑轴的中医药治疗缺血性脑卒中的研究进展。
Biomed Pharmacother. 2023 Jan;157:114056. doi: 10.1016/j.biopha.2022.114056. Epub 2022 Nov 26.
3
The interactions between traditional Chinese medicine and gut microbiota in cancers: Current status and future perspectives.中医药与癌症肠道菌群相互作用:现状与展望。
Pharmacol Res. 2024 May;203:107148. doi: 10.1016/j.phrs.2024.107148. Epub 2024 Mar 22.
4
What Makes the Gut-Lung Axis Working? From the Perspective of Microbiota and Traditional Chinese Medicine.是什么让肠-肺轴发挥作用?从微生物群和中医的角度来看。
Can J Infect Dis Med Microbiol. 2024 Jan 18;2024:8640014. doi: 10.1155/2024/8640014. eCollection 2024.
5
Traditional Chinese medicine for the treatment of Alzheimer's disease: A focus on the microbiota-gut-brain axis.中药治疗阿尔茨海默病:关注肠道菌群-肠-脑轴。
Biomed Pharmacother. 2023 Sep;165:115244. doi: 10.1016/j.biopha.2023.115244. Epub 2023 Jul 28.
6
Targeted modulation of gut microbiota by traditional Chinese medicine and natural products for liver disease therapy.中药和天然产物靶向调节肠道微生物群治疗肝脏疾病。
Front Immunol. 2023 Feb 2;14:1086078. doi: 10.3389/fimmu.2023.1086078. eCollection 2023.
7
Gut Microbiota and Aging: Traditional Chinese Medicine and Modern Medicine.肠道微生物群与衰老:中医与西医。
Clin Interv Aging. 2023 Jun 17;18:963-986. doi: 10.2147/CIA.S414714. eCollection 2023.
8
[Review of traditional Chinese medicines in ameliorating neuropsychiatric diseases by improving the levels of monoamine neurotransmitters via gut microbiota regulation].[通过调节肠道菌群改善单胺类神经递质水平来缓解神经精神疾病的中药研究综述]
Zhongguo Zhong Yao Za Zhi. 2023 Feb;48(4):853-860. doi: 10.19540/j.cnki.cjcmm.20221103.601.
9
Gut microbiota: A new target of traditional Chinese medicine for insomnia.肠道微生物群:中医药治疗失眠的新靶点。
Biomed Pharmacother. 2023 Apr;160:114344. doi: 10.1016/j.biopha.2023.114344. Epub 2023 Feb 2.
10
Could the gut microbiota reconcile the oral bioavailability conundrum of traditional herbs?肠道微生物群能否解决传统草药口服生物利用度的难题?
J Ethnopharmacol. 2016 Feb 17;179:253-64. doi: 10.1016/j.jep.2015.12.031. Epub 2015 Dec 23.

引用本文的文献

1
Gastrointestinal microbiota in treatment of gastric precancerous lesions and gastric cancer by Western and traditional Chinese medicine.胃肠道微生物群在中西医治疗胃癌前病变和胃癌中的应用
World J Clin Oncol. 2025 Aug 24;16(8):107660. doi: 10.5306/wjco.v16.i8.107660.
2
Acupuncture and nutritional parallels in obesity: a narrative review of multi-pathway modulation of the microbiota-gut-brain axis.肥胖症中的针灸与营养相似性:微生物群-肠-脑轴多途径调节的叙述性综述
Front Nutr. 2025 Aug 7;12:1610814. doi: 10.3389/fnut.2025.1610814. eCollection 2025.
3
alleviated liver damage induced by acetaminophen by regulating intestinal microbiota.

本文引用的文献

1
Regulation effect of the intestinal flora and intervention strategies targeting the intestinal flora in alleviation of pulmonary fibrosis development.肠道菌群的调节作用及针对肠道菌群的干预策略在减轻肺纤维化进展中的作用
Biosci Microbiota Food Health. 2024;43(4):293-299. doi: 10.12938/bmfh.2023-100. Epub 2024 Mar 14.
2
The involvement of effector memory CD4 T cells in mediating the impact of genus gut microbiota on Alzheimer's disease: a Mendelian randomization study.效应记忆CD4 T细胞在介导肠道微生物群属对阿尔茨海默病影响中的作用:一项孟德尔随机化研究
Front Aging Neurosci. 2024 Aug 7;16:1423707. doi: 10.3389/fnagi.2024.1423707. eCollection 2024.
3
通过调节肠道微生物群减轻对乙酰氨基酚诱导的肝损伤。
Front Microbiol. 2025 Jul 1;16:1589946. doi: 10.3389/fmicb.2025.1589946. eCollection 2025.
4
Yi-Fei-Tong-Bi Decoction Alleviates Bleomycin Induced Pulmonary Fibrosis in Mice.益肺通痹汤减轻博来霉素诱导的小鼠肺纤维化。
Drug Des Devel Ther. 2025 May 15;19:3983-3995. doi: 10.2147/DDDT.S515368. eCollection 2025.
5
Radix Remitted Intestine Damage in Mice Induced by via Mediating Antioxidant Defense, Inflammatory Mediators, and Restoring Gut Microbiota.通过介导抗氧化防御、炎症介质和恢复肠道微生物群减轻小鼠的肠损伤。 你提供的原文似乎不太完整或存在一些拼写错误,“Radix Remitted”表述不太准确,可能影响更精准的理解。
Vet Sci. 2025 Apr 10;12(4):354. doi: 10.3390/vetsci12040354.
6
Chinese herbal medicine improves antioxidant capacity of chicken liver at high stocking density involved gut-liver microbiota axis based on multi-omics technologies.基于多组学技术,中草药通过肠道-肝脏微生物群轴提高高饲养密度下鸡肝脏的抗氧化能力。
Poult Sci. 2025 May;104(5):105015. doi: 10.1016/j.psj.2025.105015. Epub 2025 Mar 11.
7
Gut-Brain Axis-Based Polygala Tenuifolia and Magnolia Officinalis Improve D-gal-Induced Cognitive Impairment in Mice Through cAMP and NF-κB Signaling Pathways.基于肠-脑轴的远志和厚朴通过cAMP和NF-κB信号通路改善D-半乳糖诱导的小鼠认知障碍
Drug Des Devel Ther. 2025 Mar 13;19:1869-1894. doi: 10.2147/DDDT.S506545. eCollection 2025.
8
Rising of natural therapies: Potential and challenges of traditional Chinese medicine in the management of gastrointestinal diseases.自然疗法的兴起:中医在胃肠疾病管理中的潜力与挑战
World J Gastroenterol. 2025 Mar 7;31(9):103145. doi: 10.3748/wjg.v31.i9.103145.
The microbiota: a crucial mediator in gut homeostasis and colonization resistance.
微生物群:肠道稳态和定植抗性的关键调节因子。
Front Microbiol. 2024 Aug 6;15:1417864. doi: 10.3389/fmicb.2024.1417864. eCollection 2024.
4
Exploring the Potential of Probiotics and Prebiotics in Major Depression: From Molecular Function to Clinical Therapy.探讨益生菌和益生元在重度抑郁症中的潜力:从分子功能到临床治疗。
Probiotics Antimicrob Proteins. 2024 Dec;16(6):2181-2217. doi: 10.1007/s12602-024-10326-z. Epub 2024 Jul 30.
5
(Sangzhi) Alkaloids Alleviate Diabetic Nephropathy through Improving Gut Microbiota Disorder.桑枝生物碱通过改善肠道微生物紊乱缓解糖尿病肾病。
Nutrients. 2024 Jul 20;16(14):2346. doi: 10.3390/nu16142346.
6
Gut-Liver-Pancreas Axis Crosstalk in Health and Disease: From the Role of Microbial Metabolites to Innovative Microbiota Manipulating Strategies.健康与疾病中的肠-肝-胰轴相互作用:从微生物代谢产物的作用到创新的微生物群调控策略。
Biomedicines. 2024 Jun 24;12(7):1398. doi: 10.3390/biomedicines12071398.
7
Different effects of acute and chronic oxidative stress on the intestinal flora and gut-liver axis in weaned piglets.急性和慢性氧化应激对断奶仔猪肠道菌群及肠-肝轴的不同影响。
Front Microbiol. 2024 Jun 17;15:1414486. doi: 10.3389/fmicb.2024.1414486. eCollection 2024.
8
The link between gut microbiome and Alzheimer's disease: From the perspective of new revised criteria for diagnosis and staging of Alzheimer's disease.肠道微生物组与阿尔茨海默病之间的联系:从新修订的阿尔茨海默病诊断和分期标准的角度来看。
Alzheimers Dement. 2024 Aug;20(8):5771-5788. doi: 10.1002/alz.14057. Epub 2024 Jun 28.
9
Lactobacillus rhamnosus GG ameliorates triptolide-induced liver injury through modulation of the bile acid-FXR axis.鼠李糖乳杆菌 GG 通过调节胆汁酸-FXR 轴改善雷公藤内酯醇诱导的肝损伤。
Pharmacol Res. 2024 Aug;206:107275. doi: 10.1016/j.phrs.2024.107275. Epub 2024 Jun 20.
10
Role of Gut Microecology in the Pathogenesis of Drug-Induced Liver Injury and Emerging Therapeutic Strategies.肠道微生态在药物性肝损伤发病机制中的作用及新兴治疗策略。
Molecules. 2024 Jun 4;29(11):2663. doi: 10.3390/molecules29112663.